Novartis misses quarterly sales, profit estimates as Entresto generics hit growth
SWISS drugmaker Novartis reported first-quarter core operating profit and sales below market expectations on Tuesday, as generic competition…
Novartis’ new drugs outweigh Entresto decline in Q3
Novartis’ third-quarter results have exemplified the reason for its recent deal-making activity, as heart failure therapy Entresto finally…